Novel approaches in the development of immunopotentiating reconstituted influenza virosomes as efficient antigen carrier systems.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Vaccine

• Publication date

  2003-01-30

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S0264-410X(02)00567-4PMID 12531327
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Virosome-mediated delivery of protein antigens to dendritic cells.

  2002cited by this paper
• Targeting her-2/neu with antirat Neu virosomes for cancer therapy.

  2002cited by this paper
• The 1-127 HA2 construct of influenza virus hemagglutinin induces cell-cell hemifusion.

  2001cited by this paper
• Perspectives: towards a peptide-based vaccine against hepatitis C virus.

  2001cited by this paper
• Exploiting Conformationally Constrained Peptidomimetics and an Efficient Human‐Compatible Delivery System in Synthetic Vaccine Design

  2001cited by this paper
• Enhanced cytotoxicity of doxorubicin encapsulated in liposomes with reconstituted Sendai F-proteins.

  2001cited by this paper
• Exploiting Conformationally Constrained Peptidomimetics and an Efficient Human‐Compatible Delivery System in Synthetic Vaccine Design

  2001cited by this paper
• Membrane structure and fusion-triggering conformational change of the fusion domain from influenza hemagglutinin

  2001cited by this paper
• Intranasal immunization with mumps virus DNA vaccine delivered by influenza virosomes elicits mucosal and systemic immunity.

  2000cited by this paper
• IRIV-adjuvanted hepatitis A vaccine: in vivo absorption and biophysical characterization.

  2000cited by this paper
• Use of reconstituted influenza virus virosomes as an immunopotentiating delivery system for a peptide‐based vaccine

  1999cited by this paper
• Phase 1 Evaluation of Intranasal Virosomal Influenza Vaccine with and without Escherichia coli Heat-Labile Toxin in Adult Volunteers

  1999cited by this paper
• The ectodomain of HA2 of influenza virus promotes rapid pH dependent membrane fusion.

  1999cited by this paper
• Immunogenicity of trivalent subunit versus virosome-formulated influenza vaccines in geriatric patients.

  1997cited by this paper
• H+-induced Membrane Insertion of Influenza Virus Hemagglutinin Involves the HA2 Amino-terminal Fusion Peptide but Not the Coiled Coil Region*

  1996cited by this paper
• Immunogenicity and adverse effects of inactivated virosome versus alum-adsorbed hepatitis A vaccine: a randomized controlled trial.

  1996cited by this paper
• Prospects for hepatitis C vaccine.

  1995cited by this paper
• Immunogenicity of new virosome influenza vaccine in elderly people.

  1994cited by this paper
• Evidence for H(+)-induced insertion of influenza hemagglutinin HA2 N-terminal segment into viral membrane.

  1994cited by this paper
• The neuraminidase of influenza virus

  1989cited by this paper

• Skin and soft tissue infections

  2021cites this paper
• Protective Efficacy in a Hamster Model of a Multivalent Vaccine for Human Visceral Leishmaniasis (MuLeVaClin) Consisting of the KMP11, LEISH-F3+, and LJL143 Antigens in Virosomes, Plus GLA-SE Adjuvant

  2021cites this paper
• Influenza Virus: Dealing with a Drifting and Shifting Pathogen

  2018cites this paper
• Lipid-based nanovesicles for nanomedicine.

  2016cites this paper
• Engineered interfaces with polyelectrolyte multilayers, lipid bilayer membranes and virosomes for biomedical applications

  2016cites this paper
• Virosome engineering of colloidal particles and surfaces: bioinspired fusion to supported lipid layers.

  2016cites this paper
• Mucosal vaccines: a paradigm shift in the development of mucosal adjuvants and delivery vehicles

  2015cites this paper
• Toll-like receptor-based adjuvants: enhancing the immune response to vaccines against infectious diseases of chicken

  2014cites this paper
• Characterization of avian influenza H5N1 virosome

  2014cites this paper
• A human-derived protein SBP (HBsAg-binding protein) can bind to hepatitis B virus surface antigen (HBsAg) and enhance the immune response to hepatitis B virus (HBV) vaccine.

  2013cites this paper
• Lipoidal soft hybrid biocarriers in pharmacotherapeutics.

  2013cites this paper
• Towards the development of a multicomponent, nanoscale oral vaccine delivery system targeting infectious bursal disease (IBD)

  2013cites this paper
• Vaccination Strategies against Malaria: novel carrier(s) more than a tour de force.

  2012cites this paper
• Multicomponent Vaccine Delivery Systems for Subcellular Targeting of Antigen and Molecular Adjuvant.

  2011cites this paper
• Novel adjuvants and delivery systems for enhancing immune responses induced by immunogens

  2011cites this paper
• Enhancement of immunogenicity of a virosome-based avian influenza vaccine in chickens by incorporating CpG-ODN.

  2011cites this paper
• Inactivated Influenza Vaccines

  2011cites this paper
• Implication of gut immunology in the design of oral vaccines.

  2010cites this paper
• The ABC of clinical and experimental adjuvants--a brief overview.

  2010cites this paper
• Novel Approaches for Drug Targeting using Virosomes

  2009cites this paper
• Influenza vaccination in the elderly: seeking new correlates of protection and improved vaccines.

  2008cites this paper
• Various carrier system(s) -mediated genetic vaccination strategies against malaria - Retracted

  2008cites this paper
• Various carrier system(s)- mediated genetic vaccination strategies against malaria - Retracted

  2008cites this paper
• A new and versatile virosomal antigen delivery system to induce cellular and humoral immune responses.

  2007cites this paper
• Alternative approaches in the preparation and growth of influenza B vaccine viruses

  2007cites this paper
• Applications of Influenza Virosomes as a Delivery System

  2006cites this paper
• Clinical applications of virosomes in cancer immunotherapy

  2006cites this paper
• Efficient induction of tumoricidal cytotoxic T lymphocytes by HLA-A0201 restricted, melanoma associated, L(27)Melan-A/MART-1(26-35) peptide encapsulated into virosomes in vitro.

  2005cites this paper
• Influenza vaccines: crossing the translational gap to improve outcomes in the elderly

  2005cites this paper
• Antigen-decorated shell cross-linked nanoparticles: synthesis, characterization, and antibody interactions.

  2005cites this paper
• Virosome and ISCOM vaccines against Newcastle disease: preparation, characterization and immunogenicity.

  2004cites this paper
• Liposomes and virosomes as delivery systems for antigens, nucleic acids and drugs.

  2004cites this paper
• Concepts in DNA immunization overcoming viral diversity and enhancing plasmid immunogenicity

  2004cites this paper
• From Microbiology and Tumor Biology Center (MTC), Karolinska Institutet and the Swedish Institute for Infectious Disease Control, Stockholm, Sweden.

  2004cites this paper
• Bacterial ghosts--biological particles as delivery systems for antigens, nucleic acids and drugs.

  2004cites this paper
• Influenza virosomes enhance class I restricted CTL induction through CD4+ T cell activation.

  2004cites this paper